Protalix BioTherapeutics, Inc. (PLX)

ASE – Real Time Price. Currency in USD

2.66

+0.23 (9.67%)

Market open: Aug 12, 2026, 11:27 AM EDT

2.40

-0.03 (-1.23%)

Previous after-hours: Aug 11, 2026, 7:44 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

05.08.2026

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel, Aug. 5, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced that it will release its financial results for the quarter ended June 30, 2026 and provide a business update on August 12, 2026.

Videos

No Data

There is no data to display

Protalix BioTherapeutics, Inc. (PLX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videos

No Data

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videos

No Data

Search stocks

Protalix BioTherapeutics, Inc. (PLX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videos

No Data

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Videos

No Data